Anti-CCN6/ LIBC/ PPAC functional antibody
Anti-CCN6/ LIBC/ PPAC functional antibody for cell culture, ELISA & in-vivo assay
Go to CCN6/CCN6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T23655-Ab-1/ GM-Tg-hg-T23655-Ab-2 | Anti-Human CCN6 monoclonal antibody | Human |
GM-Tg-rg-T23655-Ab-1/ GM-Tg-rg-T23655-Ab-2 | Anti-Rat CCN6 monoclonal antibody | Rat |
GM-Tg-mg-T23655-Ab-1/ GM-Tg-mg-T23655-Ab-2 | Anti-Mouse CCN6 monoclonal antibody | Mouse |
GM-Tg-cynog-T23655-Ab-1/ GM-Tg-cynog-T23655-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CCN6 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T23655-Ab-1/ GM-Tg-felg-T23655-Ab-2 | Anti-Feline CCN6 monoclonal antibody | Feline |
GM-Tg-cang-T23655-Ab-1/ GM-Tg-cang-T23655-Ab-2 | Anti-Canine CCN6 monoclonal antibody | Canine |
GM-Tg-bovg-T23655-Ab-1/ GM-Tg-bovg-T23655-Ab-2 | Anti-Bovine CCN6 monoclonal antibody | Bovine |
GM-Tg-equg-T23655-Ab-1/ GM-Tg-equg-T23655-Ab-2 | Anti-Equine CCN6 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T23655-Ab-1/ GM-Tg-hg-T23655-Ab-2; GM-Tg-rg-T23655-Ab-1/ GM-Tg-rg-T23655-Ab-2; GM-Tg-mg-T23655-Ab-1/ GM-Tg-mg-T23655-Ab-2; GM-Tg-cynog-T23655-Ab-1/ GM-Tg-cynog-T23655-Ab-2; GM-Tg-felg-T23655-Ab-1/ GM-Tg-felg-T23655-Ab-2; GM-Tg-cang-T23655-Ab-1/ GM-Tg-cang-T23655-Ab-2; GM-Tg-bovg-T23655-Ab-1/ GM-Tg-bovg-T23655-Ab-2; GM-Tg-equg-T23655-Ab-1/ GM-Tg-equg-T23655-Ab-2 |
Products Name | Anti-CCN6 monoclonal antibody |
Format | mab |
Target Name | CCN6 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-CCN6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T23655-Ag-1 | Recombinant multi-species CCN6/ LIBC/ PPAC protein |
Cytokine | GM-Tg-g-T23655-Ag-1 | WNT1 inducible signaling pathway protein 3 (WISP3) protein |
ORF Viral Vector | pGMLP000776 | human WISP3 Lentivirus plasmid |
ORF Viral Vector | vGMLP000776 | human WISP3 Lentivirus particle |
ORF Viral Vector | pGMLPm003970 | mouse Wisp3 Lentivirus plasmid |
ORF Viral Vector | vGMLPm003970 | mouse Wisp3 Lentivirus particle |
Target information
Target ID | GM-T23655 |
Target Name | CCN6 |
Gene ID | 8838,327743,499461,695430,100686448,101086230,100849041,100072430 |
Gene Symbol and Synonyms | CCN6,Gm735,LIBC,PPAC,PPD,PPRD,RGD1564120,WISP-3,WISP3 |
Uniprot Accession | O95389 |
Uniprot Entry Name | CCN6_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, Cytokine Target |
Disease | N/A |
Gene Ensembl | ENSG00000112761 |
Target Classification | N/A |
The target: CCN6, gene name: CCN6, also named as LIBC, PPAC, PPD, WISP-3, WISP3. This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like domain. This gene is overexpressed in colon tumors. It may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. Mutations of this gene are associated with progressive pseudorheumatoid dysplasia, an autosomal recessive skeletal disorder, indicating that the gene is essential for normal postnatal skeletal growth and cartilage homeostasis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.